Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of March 21 to 25, 2022. This […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of March 21 to 25, 2022. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
CDC: Vaccinated More Likely to Die During Omicron Wave If They Got J&J Shot
FRIDAY, March 25, 2022 (HealthDay News) — The COVID-19-related death rate among Americans who received Johnson & Johnson’s COVID-19 vaccine was more than double that of people who received other vaccines, new data from the omicron surge show.
ACC: Pericardial Effusion Prevalent in Hospitalized COVID-19 Patients
FRIDAY, March 25, 2022 (HealthDay News) — Pericardial effusion is prevalent among hospitalized patients with COVID-19, but is rarely due to pericarditis, according to a study published online March 21 in the Journal of the American Heart Association, ahead of presentation at the annual meeting of the American College of Cardiology, held from April 2 to 4 in Washington, D.C.
Psychotropic Meds Tied to Risk for Post-COVID Dementia in Seniors
FRIDAY, March 25, 2022 (HealthDay News) — Pre-COVID-19 psychotropic medication use is associated with higher risk for incident dementia following hospitalization for COVID-19 (post-COVID dementia) in older adults, according to a study published online March 18 in Frontiers in Medicine.
Airlines Ask Biden to Drop Mask Mandates, COVID-19 Testing
THURSDAY, March 24, 2022 (HealthDay News) — As COVID-19 hospitalizations and deaths drop across the United States, the chief executives of the country’s largest airlines have asked President Joe Biden to let a federal mask mandate at airports and on planes to lapse next month. Also included in the request is the dropping of COVID-19 testing for international travelers arriving in the United States.
Risk for Myocarditis Low After Third Dose of BNT162b2 Vaccine
THURSDAY, March 24, 2022 (HealthDay News) — Among military recruits in Israel, the risk for f myocarditis was low after a third dose of the BNT162b2 vaccine, according to a research letter published online March 17 in the Journal of the American Medical Association.
Fourth mRNA COVID-19 Vaccine Immunogenic, Safe
THURSDAY, March 24, 2022 (HealthDay News) — A fourth dose of mRNA COVID-19 vaccine is immunogenic and safe, but has limited effectiveness against severe acute respiratory syndrome coronavirus 2 infection, according to a study published online March 16 in the New England Journal of Medicine.
Free COVID-19 Tests, Treatments for Uninsured Americans Cut for Lack of Funding
WEDNESDAY, March 23, 2022 (HealthDay News) — Uninsured Americans will no longer be covered for free COVID-19 tests and treatments because of the budget impasse in Congress, a Biden administration official said Tuesday.
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer 
4CMenB Vaccine Confers Modest Protection Against Gonorrhea in Teens 
AAP Releases Influenza Vaccine Recommendations for All Children 6 Months and Older 
Most U.S. Adults Unsure Which Vaccines CDC Recommends During Pregnancy .jpg)
Pregnancy Complications Rare for Women Receiving CAR T-Cell Therapy 
Higher Parental Vitamin B12 Tied to Lower Prevalence of Birth Defects 
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children 
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
